Share

Discover scientific breakthroughs

transforming therapeutics and diagnostics

Explore the frontiers of molecular and cell biology

where the mysteries of life are being unlocked at the microscopic level

Institute of Molecular and Cell Biology (IMCB)

At the Institute of Molecular and Cell Biology (IMCB), we are dedicated to harnessing biology for transformational biotherapeutics and diagnostics. We aim to be a leading, world-class biomedical research institute. We foster scientific excellence, a collaborative team culture, and talent mentorship to drive high-impact innovative solutions for Asian Biology.  

With a legacy as Pioneers of the Past, Innovators of the Present, and Trailblazers for the Future, IMCB has built a strong track record of developing high-impact and innovative solutions. Not only do we place a strong emphasis on building collaborative science across Singapore's ecosystem, we are also committed to nurturing the next generation of scientific talents.  

Science

IMCB drives cutting-edge research in three key strategic areas: Cancer Signalling & Therapy, Cellular & Molecular Therapy, and Neurometabolism in Health & Disease. This multifaceted approach underscores IMCB's commitment to translating fundamental research into impactful clinical applications, unlocking new possibilities for prevention and treatment. By fostering a collaborative and interdisciplinary environment, IMCB accelerates the discovery of innovative solutions to complex health challenges.

people

At IMCB, our diverse team drives groundbreaking research in cancer, neuroscience, and regenerative medicine. Our collaborative environment and commitment towards talent development, empowers us to advance global health through innovation.

 

Technology Platforms

IMCB offers advanced platforms for preclinical drug discovery and development. Managed by the IMCB Horizontal Innovative Technology Division, these platforms deliver high-quality services and enable next-generation technology development.
Latest News

Nr1h2: A KEY TRANSCRIPTION FACTOR UNLOCKS NEW POTENTIAL IN STEM CELL-BASED EMBRYO MODELS

Read More

IMPACT at IMCB: Fostering Postdoctoral Collaboration and Development

Celebrating IMCB's Success at SME Tech Day 2024

SCIENTISTS DISCOVER HOW EXCESSIVE RED MEAT CONSUMPTION INCREASES COLORECTAL CANCER RISK

Celebrating Mentorship Excellence: STAR Mentor Award 2024

Understanding How Enterovirus-A71 Causes Neurodegeneration in Human Motor Neurons

UNVEILING THE DIVERSITY OF MOTILE CILIA: A BREAKTHROUGH IN UNDERSTANDING CILIARY FUNCTION

IMCB Leads Collaborative Efforts at the SIMM-IMCB-ZIDD Joint Research Symposium: Advancing Biomedical Research Between China and Singapore

New research shows patients with rare cancers face increased risk of developing anxiety and depression

IMCB signs agreement with Cell Genesis Pte Ltd to advance cell therapy research for diabetes

A*STAR Scientists: Building Tomorrow's Science Today

REDUCING STRESS IN FARMED FISH: A NEW TOOL FOR IMPROVING AQUACULTURE PRACTICES

Revolutionizing Brain Cancer Treatment: Key Target Discovered by Our Research Team

NEW RESEARCH REVEALS LINK BETWEEN SPINAL MUSCULAR ATROPHY (SMA) AND LIVER DAMAGE

INTERNATIONAL RESEARCH TEAM UNVEILS IMPACT OF EAST ASIAN GENE VARIANT ON TYPE 2 DIABETES RISK

The surprising interplay between metabolism and mind

Scientists Discover How Deadly Skin Cancer Evades The Human Immune System

Xinyi SU: IMCB Executive Director

Congratulations to Associate Professor Su Xinyi on her official appointment as Executive Director of IMCB, effective from March 1, 2024.

Nurturing the next generation of scientific talents

Overcoming barriers in brain cancer

Stories About Us




Upcoming Events

Connect with us